With millions of Floridians still without power after Hurricane Irma, the Internal Revenue Service has announced its making it easier to tap retirement account money for needs related to Irmas fury. It applies to those who live in designated disaster areasand to those who live elsewhere who want
I want to retire at age 55. I contribute to several retirement savings plans but worry I'll be penalized for withdrawing my savings early. I want to invest additional money somewhere else. Where should I invest? --Dave
Many of us dream of retiring long before our 65th birthday and having more ti
Seadrill Ltd (NYSE:SDRL) is deep into penny-stock land these days. A low-priced stock is often a bad investment. Just because it’s cheap, doesn’t mean it’s a bargain. Too often, while there can be huge gains in penny stocks, the risks are huge, as well. Given its recent problems, SDRL stock is not what it once was.
Seadrill used to be a high-flying company.....More>>>
Below is my list of the top gold & silver mining stock takeover targets. None of them are producers, but they all have very lucrative properties. Plus, they are all undervalued. Most of them have very advanced projects.
It’s been a long time since Valeant Pharmaceuticals (NYSE:VRX) stock was in a legitimate uptrend. Despite the hiring of a new CEO last year to right the ship, Valeant’s share price has continued to fall.
The question that investors must ask now isn’t when Valeant will turn things around. Instead, the key question is whether it will happen at all. Can Valeant Pharmaceuticals....More>>>
Best Biotech ETF: The biotech sector has been greatly outperforming the broader markets over the past three months. In fact, the Nasdaq Biotechnology sector has climbed more than 14% since June, while the Dow is up just 2% in that time.
And we see those biotech gains continuing from here. That’s why we’re bringing readers the best biotech ETF to buy now.
Several days ago Fitbit (FIT) and Dexcom (DXCM) announced they are partnering to develop CGM (continuous glucose monitoring) solutions for people living with diabetes. The first product will incorporate DXCM's CGM data and bridge it with FIT's new Ionic watch. Users of Android and iOS devices wou